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Abstract
Introduction Quality of life of people with advanced
dementia living in nursing homes is often suboptimal.
Family caregivers can feel frustrated with limited
contact with their relatives, which results in visits that
are perceived as stressful and not very meaningful. Few
psychosocial interventions are specifically developed
for people with advanced dementia, and actively involve
family caregivers or volunteers. Also, interventions usually
stop when it becomes difficult for people to participate.
The Namaste Care Family programme aims to increase
the quality of life of people with advanced dementia, and
improve family caregiving experiences through connecting
to people and making them comfortable.
Methods and analysis Our study will evaluate the effects
of the Namaste Care Family programme on quality of
life of people with advanced dementia living in nursing
homes and family caregiving experiences using a clusterrandomised controlled trial. Longitudinal analyses will be
performed taking into account clustering at the nursing
home level. Both a cost-effectiveness and a cost-utility
analysis from a societal perspective will be performed.
We will modify the Namaste Care Family programme to
increase family and volunteer involvement in ongoing and
end-of-life care. Data collection involves assessments by
family caregivers, nursing staff and elderly care physicians
using questionnaires, and observations by the researchers
at baseline and multiple times over 12 months. The last
questionnaire will be sent up to month 24 after the death
of the person with dementia. During semistructured
interviews, the feasibility, accessibility and sustainability of
the Namaste Care Family programme will be assessed.
Ethics and dissemination The study protocol is
approved by the Medical Ethics Review Committee of
the VU University Medical Center in Amsterdam (protocol
no. 2016.399) and registered with the Nederlands Trial
Register (NTR5692). The findings will be disseminated
via publications in peer-reviewed journals, conference
presentations and presentations for healthcare
professionals where appropriate.

Strengths and limitations of this study
►► The Namaste Family Care programme offers a novel

approach to involve family caregivers and volunteers
in care of nursing home residents with advanced dementia and at the end of life that is subjected to a
thorough (cost-)effectiveness and process evaluation during its implementation.
►► A large sample of at least 192 people with advanced
dementia living in at least 16 nursing homes—
equally randomised to the intervention group and
the usual care group—will be recruited to allow
for detection of a possible meaningful difference in
change of quality of life and family experiences.
►► A design with multiple follow-up assessments per
resident is used to increase power, to enable longitudinal analyses and to allow for analyses of mediators and moderators.
►► Nursing staff, elderly care physicians and family caregivers cannot be blinded to the treatment
condition due to the nature of the intervention programme, but parts of the observations are blinded.
Trial registration number NTR5692.

Introduction
Background and rationale
Currently, 47.5 million people are living with
dementia worldwide and the prevalence is
projected to double every 20 years.1 Dementia
is a progressive, life-limiting disease without
an imminent cure or effective drug treatment. Although a number of psychosocial
interventions are available for people with
dementia, few specifically target people with
advanced dementia.2 Moreover, the end-oflife phase is usually not included. Experts in
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dementia and palliative care endorse the benefits of palliative care in advanced dementia.3 It is therefore of vital
importance to identify psychosocial interventions which
at least sustain, but preferably improve, the quality of life
of people with (advanced) dementia and to develop and
provide high-quality end-of-life care.
When people with dementia are admitted to a longterm care facility, most of the care is taken over by professionals. However, previous research has shown that the
burden for family caregivers (eg, family, relatives, friends)
often remains high,4 and family caregivers find it difficult
to connect meaningfully with people with dementia in
the advanced stages. Family caregivers can become frustrated if contact with the person with dementia is limited
by aphasia and cognitive impairment, resulting in experiencing their visits as stressful and not very meaningful.5
Also, most people with dementia manifest neuropsychiatric symptoms such as anxiety, restlessness, agitation and
aggression over the course of the disease. The prevalence
of neuropsychiatric symptoms increases as the disease
progresses,6 7 and challenging behaviours commonly
occur in nursing home residents with advanced dementia
and even—although possibly to a lesser extent—at the
end of life.8 9 Neuropsychiatric symptoms are considered
the most distressing, difficult and burdensome aspects of
caring for people with dementia.10–12
With the progression of dementia, difficulties in
communication and in performing activities of daily
living occur. Therefore, people with advanced dementia
become less engaged with their environment and with
those around them, and as a result, quality of life may
decrease.13–16 People with advanced dementia may be
isolated in their rooms or hallways as they cannot participate anymore in the regular activities that are offered
in the nursing home.17 18 The presence of neuropsychiatric symptoms makes it more difficult to engage people
with advanced dementia in meaningful activities and may
further increase the risk of isolation. These behaviours
may arise from unmet needs.19–21 Psychosocial needs of
people with dementia, such as the need to engage in daily
individualised activities and care, should therefore not
be ignored in long-term care.22 Also, evidence supports
that psychosocial interventions can improve a number of
outcomes in people with dementia, including neuropsychiatric symptoms.23–25
Psychosocial interventions for people with dementia
living in nursing homes often do not involve family caregivers or lack evaluation of the effects on family caregiving experiences. Ideally, a programme that involves
family caregivers should be easy to implement, while it
does not require extensive resources and can be tailored
to the individual, as personalised interventions have been
proven to be the most effective interventions for nursing
home residents with more severe dementia, and particularly for people with challenging behaviours.26
An intervention which may meet these requirements is
a programme called Namaste Care,27 a daily multidimensional care programme with psychosocial, sensory and
2

spiritual components that incorporates person-centred
and palliative care approaches. By respecting each person
with dementia as a unique individual, the programme
pays attention to the individual’s dignity until death.28 By
engaging people with dementia in meaningful activities
on a daily basis, the programme attends to their psychological, bodily and spiritual needs.27 29 30 Namaste Care is
designed to reach people with dementia who are socially
withdrawn and who no longer benefit from the regular
recreational social and group activities, have severe cognitive impairments, require care with all activities of daily
living, have limited verbal abilities and spend a lot of time
sleeping.27 29 Namaste Care is also deemed beneficial for
people with behavioural symptoms of dementia.29 It aims
to increase the quality of life of people with advanced
dementia who live in long-term care facilities. There are
indications that the programme successfully improved
the lives of people with advanced dementia and their
families at no extra healthcare costs.30–32 For example, in
the UK, implementation of the programme was achieved
with only modest expenditures and no change in staffing
levels.30 Further, it reduced behavioural symptoms of
dementia and the use of psychotropic medication in
people with dementia.29 33 34
Additional research about the effects of Namaste
Care is needed. Although less behavioural symptoms of
dementia have been reported and qualitative work indicated improved quality of life of people with advanced
dementia,29 30 34 35 these outcomes have not yet been
tested in a large sample with a randomised control group.
Furthermore, when effective, we need to identify the
effective elements of the programme and whether the
programme is more effective in specific subgroups. Also,
it is important to assess the impact on family caregiver-related outcomes and evaluate cost-effectiveness from a
societal perspective. This study will contribute in fulfilling
some of these gaps in the current knowledge about the
effects of Namaste Care and helps to further improve and
disseminate the programme. This is important as Namaste
Care has the potential to positively change how end-of-life
care is provided to people with advanced dementia.
Objectives
The primary objective of this cluster-randomised
controlled trial will be to examine the effectiveness of the
Namaste Care Family programme, an adapted version
of the original Namaste Care, on (1) the quality of life
of people with advanced dementia living in nursing
homes and on (2) caregiving experiences of their family
caregiver. The adaptations of Namaste Care include an
emphasis on family caregivers and volunteers providing
the care in collaboration with nursing staff, and more
explicit and elaborate incorporation of end-of-life care.
The secondary objects include (3) assessing the cost-effectiveness of the programme compared with usual
care; (4) examining the effects of Namaste Care Family
programme on discomfort, comfort in dying, behavioural
symptoms of dementia, psychotropic medication use and
Smaling HJA, et al. BMJ Open 2018;8:e025411. doi:10.1136/bmjopen-2018-025411
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intercurrent health problems in nursing home residents
with dementia; (5) assessing the effects of Namaste Care
Family programme on family caregiver burden, guilt
and conflict in caregiving, and (anticipatory) grief in
family caregivers; (6) examining the effective elements
of the programme; (7) defining subgroup(s) in which
the intervention or elements are more effective; and
(8) conducting a process evaluation to assess feasibility,
accessibility and sustainability of the Namaste Care Family
programme.

Methods and analysis
We will conduct a cluster-randomised controlled trial. A
cluster-randomised design was chosen because the intervention is structured around groups of residents rather
than individuals and it requires a different way of working
by the nursing staff, and to minimise contamination.
The unit of randomisation will be the nursing home
or nursing home organisation. Data will be collected
between May 2016 and December 2018 in the Netherlands. The study was registerted with the Nederlands Trial
Register (NTR5692).
Recruitment of nursing homes
The study will take place in Dutch nursing homes. In the
Netherlands, a nursing home is a facility with a domestic-styled environment that provides 24-hour functional
support and (medical) care for persons who require assistance with activities of daily living and who often have
complex health needs. Although postacute rehabilitation may be provided in the nursing home, care is often
long term and often includes palliative care.36 Dutch
nursing homes employ their own multidisciplinary teams,
consisting of an elderly care physician (a specialised
physician who combines competencies of a general practitioner with those of a geriatrician) and various other
professionals (eg, nursing staff (eg, registered nurses and
certified nursing assistants), psychologist, physiotherapist,
dietician).37 There are long-stay departments specifically
for residents with dementia, so-called psychogeriatric
wards. At least 16 nursing homes with a psychogeriatric
ward will be recruited for the current study. Nursing
homes should be willing to offer the Namaste Care Family
programme for at least 2 years.
We will send the manager of the nursing home an
email with information about the study and the Namaste
Care Family programme, and an invitation to participate
in the study. After 2 weeks, a follow-up telephone call
will be made to enquire whether there is an interest to
participate. Reasons for not wanting to participate will be
recorded. If there is interest, a meeting with the manager
and/or other staff members will be scheduled to further
discuss the aims of the study and the Namaste Care Family
programme. When the nursing home decides to participate in the study, the manager will be asked to fill in a short
questionnaire to assess the characteristics of the nursing
home. Randomisation to the Namaste Care Family
Smaling HJA, et al. BMJ Open 2018;8:e025411. doi:10.1136/bmjopen-2018-025411

programme or the usual care group will be performed
(see Randomisation procedure section for more details)
and an individualised schedule is discussed to plan the
procedural steps of the study (who will do what, when and
where). Finally, the research team will organise a meeting
in the nursing home to inform all staff about the study
and the Namaste Care Family programme. The manager
will also receive templates of leaflets and other materials
to inform staff about the study.
Randomisation procedure
Included nursing homes will be matched on various
criteria that might impact the effects of the programme
on outcome measures based on the questionnaire filled
in by the manager. We will match nursing homes on
volume of psychosocial programmes and programmes
involving family caregivers in the care for the person with
dementia. We will further take into account whether or
not the ward is part of a small-scale living arrangement,
and situated in a rural versus urban area as family support
is likely to be a greater part of social life in more rural
areas of the Netherlands. Furthermore, we will match on
the number of residents on a ward and the manager’s
perceived influence of the nursing home’s religious affiliation, as this was found to be independently associated
with people with dementia dying more peacefully.38
Possible matches will be judged for appropriateness
by three researchers (HJAS, KJJ, JTvdS). Successfully
matched pairs of nursing homes will be randomised
with one nursing home being allocated to the intervention condition and the other to the usual care condition.
Randomisation is performed by a statistician who is not
involved in recruitment or data collection (PMvdV). Due
to the nature of the intervention, the group allocation
cannot be masked.
Recruitment of participants
After randomising the nursing home to a treatment condition, the recruitment of participants within the nursing
home will start. Within each nursing home, nursing staff
will be asked to indicate which residents with advanced
dementia and/or their family caregivers may benefit from
the Namaste Care Family programme. They are residents
with advanced dementia unable to participate in the
regular activity programme and residents with moderate
dementia with behavioural symptoms of dementia, having
family caregivers understanding the Dutch language and
who are willing and able to fill in questionnaires.
The family caregivers of eligible residents will be sent an
invitation letter from the nursing home, a consent form
and a participant information letter. The family caregiver
will be asked to sign and return an informed consent form
to the research team via a pre-stamped envelope. After
2 weeks, a reminder will be sent. For study participation,
written informed consent given by the family caregiver will
be required. All nursing homes will be offered a ‘family
meeting’ at their location, organised by the research team,
to inform family caregivers and volunteers about the study
3
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and the programme. Participants will have the right to withdraw from participation at any time if they wish so. No financial incentive to participate will be provided.
Intervention
The nursing homes in the intervention group will implement
the Namaste Care Family programme, a modified version
of the original Namaste Care.27 The adaptations include
an emphasis on family caregivers and volunteers providing
the care in cooperation with the nursing staff, and more
explicit and elaborate incorporation of end-of-life care. We
have developed two manuals about the Namaste Care Family
programme, one for management and one for nursing staff,
family caregivers and volunteers, based on Simard’s book27
and the British toolkit for implementing Namaste Care.39
We will make a summary available of the parts that are
specific to the adapted Family form of the intervention after
completing the study.
Namaste Care Family, similar to the original Namaste
Care, is a 7-day-a-week programme, intended to be offered
in 2-hour sessions, twice a day. The sessions take place in a
calm home-like room, the ‘Namaste room’, with soft music
or nature sounds and pleasant scents, and without external
distractions or interruptions. Each session starts with personally greeting each resident when entering the Namaste
room. Each resident is comfortably seated and screened for
signs of pain. Nutritious, appetising foods and drinks are
offered frequently to increase hydration and raise caloric
intake. During the sessions, meaningful activities and multisensory stimulation are integrated with person-centred care
and reminiscence. Extra personal care (massages; washing
the face, hands and feet; grooming; nail care) is offered
during the sessions to facilitate an experience of gentle,
caring touch. The session ends with thanking each resident
for their presence in the Namaste session and a personalised
goodbye.27 30
Nursing staff and volunteers in the intervention group will
receive a 2-hour training from the research team in which
they will learn about the principles of the Namaste Care
Family programme, the purpose and the benefits of the
programme for people with dementia, their families and
staff, and will be offered tools to develop a plan to implement, evaluate and sustain the programme in their nursing
home. The training will take place after the baseline assessment. One month after the start of the Namaste Care Family
programme, the manager or ‘Namaste coordinator’ (ie,
person in charge of all practical aspects of the programme in
the nursing home) in each nursing home will be contacted
by the research team to evaluate the first month of the
programme and, if they prefer, to discuss questions and
problems. The primary researcher (HJAS) will participate
in or observe at least two Namaste sessions in each nursing
home, one in the first 3 months and one after 6 months from
the start of the programme, and will evaluate these sessions
afterwards with the nursing staff and will provide feedback
to improve the implementation of the programme when
needed.
4

Patient and public involvement
Patients (ie, people with advanced dementia) were not
involved in the research design. The research protocol
was reviewed by family caregivers and people with mild
dementia. Family caregivers were consulted to select the
best questionnaires for measuring positive caregiving
experiences for family caregivers of people with advanced
dementia. Family caregivers will be asked to review the
participant information letter that will be used for the
recruitment. Also, family caregivers and volunteers will be
invited to participate in the Namaste sessions. Family caregivers will receive a newsletter every 3 to 4 months with an
update of the progress of the study and, in time, the results
of the study.
Data collection
Figure 1 outlines the trial recruitment and data collection process. Table 1 shows an overview of the instruments
that will be used for assessment. Questionnaires will be
made available online or on paper, depending on the
preferences of the respondent and the nursing home.
If preferred, the research team will assist in filling out the
questionnaires.
The manager of the nursing home will assign each
resident to a member of the nursing staff who knows the
resident well and can fill in the questionnaires about the
resident throughout the study. The elderly care physicians will also complete questionnaires about the residents and they may be assisted by a nurse practitioner.
All respondents will be asked to fill in the questionnaires
within 2 weeks. If needed, a reminder to fill in the questionnaire will be sent after 2 weeks.
Observations will be performed by trained research
assistants who are unfamiliar with the residents and the
assessments will last approximately 10 min per resident.
The primary researcher (HJAS) and the project coordinator will train all research assistants with an instructional video and set of examples. The research assistants
will be instructed to plan observations, if possible, at the
same time for each assessment during daytime, but not
during meals or shortly after burdensome procedures
(eg, physiotherapy, toileting or transfers). Each resident
will be observed by the same observer at each assessment whenever feasible. For the intervention group,
standard observations after the baseline assessment will
be conducted during a Namaste session. This does not
allow for blinding the research assistants for the treatment group. To minimise bias, the research assistants will
not be told any details about the intervention or study
goals. We will also plan an additional observational assessment at least 3 months after the start of the Namaste Care
Family programme after a Namaste session, performed
by a blinded research assistant who is new to the team.
To monitor inter-rater reliability, 10% to 20% of the
observations will be scored by two research assistants
independently.
Smaling HJA, et al. BMJ Open 2018;8:e025411. doi:10.1136/bmjopen-2018-025411
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Figure 1

Study flow diagram.

Primary outcome measures
Quality of life
The Quality of Life in Late-Stage Dementia (QUALID)40 41 will
be used to assess quality of life of the person with dementia.
The QUALID is a brief, proxy informant-based questionnaire consisting of 11 domain-specific items. Each item has
five response options indicating the frequency of concrete
and observable mood and performance items, such as
smiles, enjoys eating or facial expression of discomfort, over
the last week. Summed scores can range from 11 to 55 with
Smaling HJA, et al. BMJ Open 2018;8:e025411. doi:10.1136/bmjopen-2018-025411

lower scores indicating better quality of life. The QUALID,
including the Dutch translation, has good psychometric
properties.40 42 43
Positive caregiving experiences
To better understand the positive aspects of caregiving, we
will use two instruments to measure family caregivers’ caregiving experiences, one focusing specifically on positive
experiences and the other focusing on gains in dementia
caregiving.
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►► Prolonged Grief Disorder Scale (PGD),
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Potential mediators of an effect on the primary outcomes

 (Anticipatory) grief
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‘conflict with staff’
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►► Family Perceptions of Caregiving Role (FPCR),

 Guilt and conflict in caregiving
 (family caregiver)

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
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Continued

x
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x

After
Baseline Month 1 Month 3 Month 6 Month 12 death

7-item version

►► Zarit’s caregiver burden scale (ZBI),
62
►► Self-Rated Burden scale (SRB)

59 60

drinking problem, other new major medical illness or event55
►► Health problems (eg, delirium, infections, dehydration, weight loss,
comorbid diseases): items from the InterRAI—Minimum DataSet
(MDS)57 58 and Dutch End of Life with Dementia Study (DEOLD) study55

 Caregiver burden
 (family caregiver)

Family caregiver

►► Sentinel events: pneumonia, (other) febrile episode, new eating or

 (Intercurrent) health problems
(physician)

anxiety, analgesics

►► Psychotropic medication: antipsychotics, antidepressants, anti-

 Medication use
 (physician)

52

►► Neuropsychiatric Inventory Questionnaire (NPI-Q)

 Behavioural symptoms of
dementia—change (nursing
staff)

48

►► EOLD—Symptom Management (SM)

 (family caregiver)

(CAD)48

►► End-of-Life in Dementia (EOLD)—Comfort Assessment in Dying

 Comfort (in dying)
 (nursing staff)

46

►► Discomfort Scale-Dementia of Alzheimer Type (DS-DAT)

44

►► Positive Experiences Scale (PES)
45
►► Gain in Alzheimer Care Instrument (GAIN)

 Discomfort—change
 (research assistant)

Person with dementia

Secondary outcomes

 Positive caregiving
experiences—change (family
caregiver)

Family caregiver

 Quality of life of the person with ►► Quality of Life in Late-Stage Dementia (QUALID)40 41
dementia—change (nursing
staff)

Primary outcomes
Person with dementia

Measurement instrument

Time of measurement (proximate to start programme for
intervention group)

Schematic of concepts, measures and measurements to assess the (cost-)effectiveness of the Namaste Care Family programme in nursing homes

Assessment
(perspective/rater)

Table 1
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Continued

61

►► Implementation checklist Namaste Care Family programme
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 (nursing staff)
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►► Bedford Alzheimer Nursing Severity-Scale (BANS-S)

 Dementia (physician)

 Dementia severity (physician)
Societal cost variables

84

►► Mitchell’s Advanced Dementia Prognostic Tool

 Mortality risk (physician)

86

►► TOPICS-MDS

 Demographic information
caregiver and person with
dementia (family caregiver)

Other data

►► EOLD—Satisfaction With Care (SWC)

48

►► Person with dementia’s previously expressed preference for touch and x

 Personality
 (family caregiver)

 Satisfaction with care
 (family caregiver)

►► Informal Caregivers Survey–Minimum Data Set (TOPICS-MDS)

 Gender of person with
dementia and caregiver (family
caregiver)
being socially engaged

►► Pain Assessment in Advanced Dementia (PAINAD)

 Pain (research assistant)

x

x

x

x

x

x

x

x

►► ZBI (secondary outcome measure)
►► SRB (secondary outcome measure)

 Caregiver burden
82

x

►► NPI-Q: apathy and agitation (secondary outcome measure)

 Behavioural symptoms of
dementia

Potential moderators of an effect of the primary outcomes

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

Continued

On a continuous basis through registration forms in
the nursing home

x

►► Observed frequency of positive vocalisations

 Engagement
 (research assistant)
►► Elements implemented at the individual level
►► Time in Namaste session per participant

x

►► No and estimated duration of visits
►► No of Namaste sessions family caregiver attended

x

x

 Family caregiver visits
 (family caregiver, nursing staff)

75

adapted family

After
Baseline Month 1 Month 3 Month 6 Month 12 death

►► Family Visit Scale for Dementia (FAVS-D)

version

73

►► Person-centred Climate Questionnaire (PCQ-F),

Measurement instrument

Time of measurement (proximate to start programme for
intervention group)

 Family caregiver visit
experiences
 (family caregiver)

 Person-centredness of caring
 (family caregiver)

Assessment
(perspective/rater)

Table 1
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Continued

x

►► Hospitalisation, ambulant specialist care

 Use of healthcare services
 (physician)

►► PES (primary outcome measure)

Process evaluation
 (managers, nursing staff, family ►► Semistructured qualitative interviews to assess feasibility, accessibility
caregivers and volunteers)
and sustainability
 
(manager)
►► Short evaluation about ongoing implementation of Namaste Care
Family

 Positive caregiving
experiences—change (family
caregiver)

x

x

x

►► Informal caregiving tasks (by family caregiver and others)

 Informal caregiving costs
 (family caregiver)

 Quality of life of the person with ►► QUALID (primary outcome measure)
89
dementia—change (nursing
►► EuroQol-5D (EQ-5D)
staff)

x

►► Medication use, active substance, duration, dose

x

 Medication costs (physician)

caregiver for the intervention unrelated to the project’s research nature

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

After
Baseline Month 1 Month 3 Month 6 Month 12 death

►► Any supplies purchased, donations, extra or less time of staff and

Measurement instrument

Time of measurement (proximate to start programme for
intervention group)

 Namaste Family Care costs
 (manager, nursing staff, family
caregiver)

Assessment
(perspective/rater)

Table 1
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The Positive Experiences Scale (PES)44 for family caregivers of people with dementia will be used to measure
positive experiences by family caregivers. The PES consists
of hierarchically ordered items which vary from intrinsic
satisfaction (‘Caring for my loved one makes me feel good’)
and relational enhancement (‘During the period that I have
been providing care, my loved one and I have grown closer
(quality of our relationship is better now)’) to improvement
of competence (‘As a result of providing care, I have learnt
new things myself’) and social enhancement (‘As a result of
providing care, I have met new people’). Items are scored on
a three-point Likert scale (agree, don’t agree/don’t disagree,
disagree). In addition to the six items that have been identified as suitable for caregivers of people with dementia in
previous research, we use a seventh PES item ‘Helping has
made my relationship with my family and friends closer’, as
we expect that the Namaste Care Family programme might
have a positive influence in this regard. The PES has good
psychometric properties.44
The Gain in Alzheimer Care Instrument45 will be used
for measuring family caregivers’ gains in dementia caregiving. The scale has 10 items that make up three components: (1) personal growth, (2) gains in relationships and
(3) higher-level gains. Items are scored on a Likert scale
from 0 (disagree a lot) to 4 (agree a lot). Summed scores
can range from 0 to 40, with higher scores indicating
higher gains. The instrument has good psychometric
properties.45
Secondary outcome measures
Discomfort
The well-tested Discomfort Scale–Dementia of Alzheimer
Type (DS-DAT)46 will be used to observe discomfort in
the person with dementia. The scale uses duration and
frequency of seven negative (eg, negative vocalisation) and
two positive (eg, relaxed body language) behaviours. Each
item is scored 0–3 and summed scores range from 0 to 27
with higher scores referring to more discomfort. The Dutch
DS-DAT has good psychometric properties.47
Comfort (in dying)
The End-of-Life in Dementia—Comfort Assessment in
Dying48 comprises 14 items and consistently refers to the
quality of dying.49 This simple tool, developed for evaluation retrospectively after death, had the best psychometric
properties and feasibility to measure quality of dying in
long-term care in a combined US–Dutch study.50 A higher
total score indicates a better comfort level.
The nine items of the End of Life in Dementia—Symptom
Management (EOLD-SM)48 quantify the frequency a resident experiences the following nine symptoms and signs:
pain, shortness of breath, depression, fear, anxiety, agitation,
calm, skin breakdown and resistance to care. Frequency is
quantified on a six-point Likert scale ranging from 0 to 5 as
follows: daily, several days a week, once a week, 2 or 3 days
a month, once a month, never. The original timeline was
‘previous 90 days’, but we will adapt this timeframe to ‘last
month’. The scale ranges from 0 to 45 with higher scores
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indicating better symptom control. The EOLD-SM has
moderate to good psychometric properties.48 51
Behavioural symptoms of dementia
The Neuropsychiatric Inventory Questionnaire (NPIQ)52 will be used to measure 12 behavioural symptoms of
dementia over the past month, namely delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria,
disinhibition, irritability/lability, apathy, aberrant motor
activity, night-time behaviour disturbances and eating abnormalities. Nursing staff are asked to indicate ‘yes’ or ‘no’ to
each screening question, and to subsequently rate the presence of symptoms in terms of severity on a three-point scale
(mild, moderate, severe). The total NPI-Q severity score
ranges from 0 to 36 and represents the sum of individual
symptom scores. Distress associated with the symptom will be
measured for symptoms that are present with the NPI-Distress Scale (NPI-D) with scores ranging from 0 ‘not emotionally stressful’ to 5 ‘extremely stressful’. The total NPI-D sum
score ranges from 0 to 60. We will also include subscales of
the behavioural scales as outcome measures. The NPI-Q
provides a reliable, valid assessment of neuropsychiatric
symptoms.52 53 However, there is less evidence for validity of
subscales compared with total scores.54
Medication use and health problems
We will measure intercurrent health problems (sentinel
events) in the past 6 months: pneumonia, (other) febrile
episode, new eating or drinking problem, and other new
major medical illness or event (eg, hip fracture, stroke,
gastrointestinal bleed, cancer).55 The health condition of
the resident, including incontinence, comorbid diseases,
nutritional and hydration status, and delirium,55 will also
be measured. A clinical judgement of illness severity will be
assessed on a scale ranging from 1 (‘not ill’) to 9 (‘moribund’).56 To assess infections, dehydration and weight loss,
we will use items from the InterRAI-Minimum DataSet.57 58
The elderly care physician will be requested to provide a list
of all medication used in the week before each assessment.
Caregiver burden
We will use the shortened seven-item version of Zarit’s
well-tested caregiver burden interview (ZBI).59 60 Items
are scored on a five-point scale, with a cut-off score of ≥13
considered as a clinically significant burden.59 We will also
use a Visual Analogue Scale (VAS)61 based on the Self-Rated
Burden scale (SRB)62 for assessing the burden of family
caregiving. The family caregiver will be asked to indicate
on the VAS how burdensome they feel in caring for the
person with dementia. The VAS is anchored at 0 ‘not at
all straining’ (not hard at all) and 10 ‘much too straining’
(much too hard).
Guilt and conflict in caregiving
The Family Perceptions of Caregiving Role will be used
to measure multiple dimensions of family member
distress associated with an institutionalised relative with
dementia.63 Response options form a seven-point agreement scale.63 64 We will only use the subscales ‘conflict with
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staff over caregiving’ (10 items) and ‘guilt from perceived
failure in caregiving’ (5 items), as increased caregiver
involvement has been associated with increased feelings
of guilt and conflict with staff in an intervention helping
family caregivers create meaningful roles for themselves in
long-term care settings.64
(Anticipatory) grief
Grief will be assessed with the pre-loss and post-loss versions
of the Prigerson’s Prolonged Grief Disorder (PGD)
Scale.65 66 The post-loss version of the PGD Scale comprises
11 items from the Inventory of Complicated Grief-Revised that were slightly modified to resemble the proposed
criteria for PGD.66 Family caregivers rate the occurrence of
symptoms in the past month on a five-point scale ranging
from ‘never’ to ‘always’. We modified the Dutch PGD-1165
to refer to the pre-loss period while retaining the meaning
of the items. Two items from the English pre-loss version
that were not congruent with the Dutch post-loss items
were translated into Dutch and added to the Dutch pre-loss
questionnaire. This resulted in a 13-item pre-death grief
scale asking family caregivers how often they experience
distressing grief symptoms related to yearning, bitterness,
interpersonal disengagement and a sense of meaninglessness. The items are summed to result in an overall severity
score.
Measures to evaluate mediators
An effect of the intervention on quality of life and
family caregiving experiences may be achieved through
person-centredness of care, frequency and quality of the
family visits, engagement of the person with dementia,
received dose of the intervention and level of implementation of the Namaste Care Family programme (see table 1).
Challenging behaviour may be theorised as due to unmet
psychosocial needs which may be met by person-centred
caregiving. A person-centred caring environment (eg, ‘A
place that feels homely’)67 68 was found to improve residents’ quality of life and increased family involvement while
it decreased perceived care burden.69 The involvement of
family caregivers in dementia care was found to reduce
residents’ challenging behaviour, improve the residents’
quality of life as well as the quality of life of their family caregivers.70–72 Family caregiver perceptions of a better quality
of their visits to the person with dementia may mediate the
effects on the primary outcomes. Also, engagement with
stimuli and structured activities has been found to improve
affect and decrease behavioural symptoms of dementia.17
Finally, the dose of the intervention and the fidelity of
implementation may also mediate effects in the intervention group.
Person-centredness
Person-centredness of caring will be assessed using the
Person-centred Climate Questionnaire—family version
(PCQ-F).73 The PCQ-F is similar in content to the previously
published patient version,74 but we changed the perspective
to a proxy perspective. The 17 items of aspects about care
10

climate are rated on a six-point Likert scale ranging from 0
(‘No, I disagree completely’) to 5 (‘Yes, I agree completely’).
The total score ranges from 0 (lowest person-centred care)
to 85 (highest score for person-centred care).
Family visits
The frequency and average time of a regular visit by the
family caregiver will be measured. In the intervention
group, we will also assess if and how often the family caregiver participates in Namaste sessions.
The quality of family visits will be measured with the
Family Visit Scale for Dementia (FAVS-D).75 The FAVS-D
comprises 14 items rated on a five-point scale (‘strongly
disagree’, ‘disagree’, ‘neutral’, ‘agree’ and ‘strongly agree’).
A total score can be calculated with a higher score indicating a higher quality of the visits.
Engagement
We will measure positive vocalisations, an important
dimension of engagement.76 Positive vocalisation has been
operationalised after pilot testing observation of positive
vocalisation as any verbal, vocal utterance or noise with a
positive quality, such as sounds expressing happiness, joy
and/or satisfaction, a high-pitched noise with a definite
pleasant sound, repeating the same words with a joyful tone,
expressing joy, pleasure, happiness or satisfaction (eg, ‘I am
happy’, ‘This cake is my favourite’, laughing, singing). We
will score the presence of positive vocalisations for 7 min. A
sum score can be calculated and examples of positive vocalisations will be noted when expressed.
Fidelity of programme implementation
Nursing staff will be asked to register the activities offered
during each Namaste session for individual participants and
the time each participant spends in the Namaste session,
so an overview of elements implemented at an individual
level and a Namaste dose per participant can be made.
The researchers will visit at least two Namaste sessions in
each nursing home, once at the start of the programme
and after at least 6 months, during which the quality of the
implementation will be monitored. We will also develop a
10-item checklist to score the level of implementation of
Namaste components on a three-point scale. An implementation sum score with a possible range from 0 to 20 can be
composed by summing the items, with higher scores indicating a better implementation of the Namaste Care Family
programme.
Measures to evaluate moderators
Moderators modify the effect of the intervention, indicating subgroups in which it is more or less effective. The
baseline levels of agitation and apathy of the person with
dementia and initial caregiver burden will be examined as
potential moderators for quality of life and positive caregiving experiences, respectively. For example, it may be
more difficult to experience satisfaction from caregiving
when caregivers perceived their role as a burdensome experience.77 Agitation and apathy in people with dementia are
associated with caregiver frustration and a reduced quality
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of life. People with dementia with agitation or apathy may
benefit more from the programme, as psychosocial interventions based on person-centred care and with elements
of sensory stimulation, offering activities, and teaching the
family to connect to the person with dementia are effective
in reducing agitation and apathy in people with advanced
dementia.78 79
Other possible moderators in our study are sociodemographics (eg, gender and personality), pain and satisfaction
with care. Gender and personal characteristics impact the
caregiving experience.77 80 Planned reporting of treatment
outcomes by specific subgroups, such as gender,80 is being
encouraged to tailor interventions to specific subgroup
needs. The Namaste Care Family programme seeks to
enrich quality of life through shared activity and increased
social interaction. More personal care and touch are used
to connect to the person with dementia. The effects of the
Namaste Care Family programme on quality of life may
therefore differ depending on the previously expressed
preferences for touch and whether the person with
dementia was socially engaged.81 One of the UK studies
found Namaste Care effective in improving behaviour
only in homes with adequate pain control in place, which
suggests pain is a moderator of programme effectiveness.34
Family caregivers who are satisfied with the care may experience more positive experiences. Satisfaction with care may
also be a subjective indicator of quality of care and thus
impact the quality of life the residents.
The presence and severity of agitation and apathy in the
people with dementia will be assessed using the NPI-Q.52
Caregiver burden is measured using the ZBI59 60 and SRB.61
These instruments have been described in more detail
under Secondary outcome measures section.
Sociodemographics: gender and personality
Sociodemographic information of the family caregiver and
person with dementia will be assessed using items of the
Older Persons and Informal Caregivers Survey–Minimum
Data Set (TOPICS-MDS).61 Additionally, we will include the
two items for personality indicating the family caregiver’s
perception of the person with dementia previous preference for touch (ie, whether or not the person liked to be
touched) and being socially engaged (ie, whether or not
the person liked group activities).
Pain
The five-item Pain Assessment in Advanced Dementia82
will be used to assess pain in the person with dementia.
The items are scored during a direct 2 min observation on
a three-point scale. A sum score can be calculated with a
higher score indicating higher probability of pain (possible
range 0–10). A validated cut-off of 2 indicates probable
presence of pain.83
Satisfaction with care
The family caregiver’s satisfaction with care will be
measured with the 10-item End-of-Life in Dementia–Satisfaction With Care (EOLD-SWC).48 Items are scored on a
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four-point scale (‘strongly disagree’ to ‘strongly agree’).
The EOLD-SWC has the best psychometric properties and
feasibility for families to evaluate the quality of end-of-life
care49 50 and can also be used when a person is not at the
end-of-life stage. Higher total scores indicate higher levels
of satisfaction with care.
Other clinical characteristics
The severity of dementia will be measured with the sevenitem Bedford Alzheimer Nursing Severity-Scale (BANSS).84 Item scores range from 1 to 4, and total scores range
from 7 to 28, with a cut-off of 17 or higher indicating severe
dementia.85 Type of dementia and Mitchell’s Advanced
Dementia Prognostic Tool86 will be used to calculated a
12-month mortality risk score.
Cost-effectiveness
Costs will be measured from a societal perspective
according to a Dutch standardised data collection tool for
older people, the TOPICS-MDS.61 We will use a bottom-up
micro-costing approach to estimate intervention costs
which will include costs of supplies for Namaste Care
Family programme, any change (increase or decrease)
in staff time, and family and volunteer time investments.
Healthcare costs will include medication, hospitalisation,
and emergency room and specialist visits. For the valuation of healthcare use, standard prices published in the
Dutch costing guidelines will be used.87 Medication will be
valued using prices of the Dutch National Healthcare Institute.88 Informal care spent by family excluding time spent
on the Namaste Care Family programme will be assessed
and valued using the Dutch standard price. Societal costs
will be related to the main effect measures of quality of life
as measured by the QUALID,40 41 quality-adjusted life years
(QALY) and positive caregiving experiences measured by
the PES44 in the economic evaluation.
QALYs will be calculated using the Dutch tariff for the
EuroQol-5D (EQ-5D).89 The EQ-5D is a five-item objective
measure of health status in which items (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression)
are described by choosing one out of three possible degrees
of impairment/severity (ie, no, some, extreme). The instrument also includes a VAS anchored at 0 ‘worse imaginable
health state’ and 100 ‘best imaginable health state’. The
EQ-5D has been shown to be responsive, internally consistent and reliable when used for people with dementia or
cognitive impairment.90 91
Data management
The questionnaires and observations will be coded with
unique identification numbers to guarantee privacy. A
unique identifier will be assigned to all participants (eg,
people with dementia, family caregivers, nursing staff,
elderly care physicians and research assistants) and nursing
homes, with linkage keys to be stored separately from the
data. Respondents can choose to fill in questionnaires digitally or on paper. The data from the digital questionnaires
will be converted into a SPSS data file. The data from any
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paper questionnaire will be entered directly into a SPSS
database by research assistants. We will subject 10% of the
latter data to a random audit by a second researcher to test
the accuracy of data entry. We will store all study data on a
password-protected drive that is only accessible to members
of the research team.
Sample size
The standard power calculations to detect a relevant
difference in the primary outcomes—quality of life of
the persons with dementia and positive caregiving experiences—indicated sufficient power with eight nursing
homes per group (16 in total) and 14 residents per home
for QUALID and PES outcomes. We used the mean (M)
and SD as calculated in previous work validating the Dutch
version of the QUALID in nursing home residents with
advanced dementia (M=7.5, SD=4.9).41 For the PES, it was
analysed and provided for the subgroup of family caregivers
with dementia (M=2.9, SD=1.9).92 Clinically relevant differences in means were defined as 1.5 on the PES and 4 on the
QUALID.
Simulations were performed considering QUALID as
the primary outcome and accounting for a maximum of
four assessments per person. Power was based on the test
for an interaction between time of measurement and intervention, taking into account the three-level structure with
measurements within persons within nursing homes. The
SD (total of between subjects and between nursing homes)
for QUALID and the within-subject correlation were first
estimated using the six consecutive QUALID assessments
available from the Dutch End of Life with Dementia Study
(DEOLD) dataset,55 selecting patients with severe dementia
(BANS-S score of 17 or higher). Different scenarios were
considered where the SD and within-subject correlation
were varied around these estimates. Additionally, various
scenarios for attrition over time were considered.
Assuming, conservatively, that the full effect of the intervention occurs after 3 months, SDs between 6 and 8, up to
four consecutive follow-up assessments with several drop-out
scenarios to accommodate mortality differential for initial
QUALID score and based on an estimated survival of half
of these patients in a year follow-up as in DEOLD, we found
that the power to detect a difference of 4 QUALID points
change between the intervention and usual care groups was
between 83% and 100% for all 32 scenarios for 8 homes
per group (16 in total) and an average of 12 residents per
home. For 7 homes per group and 10 residents per home,
the power varied between 70% and 90.5%, with 28 of 32 of
scenarios presenting with over 80% of power.
However, for mediator analyses with an intracluster
correlation coefficient of 0.09 for clustering within facilities as observed in DEOLD, we prefer the larger number
of 8 nursing homes per group, and 12 residents per facility,
totalling 192 residents. These numbers will suffice to test
associations with mediators which are at least medium
in strength.93 Our aim of 192 residents will also suffice
for subsequent testing of moderators. Finally, as a rule of
thumb, with 192 residents, we can test between 12 and 19
12

covariates per analysis. In all, with these conservative estimates, power is large to very large to detect the expected
medium to large effect sizes.
Analysis plan
Analyses of effects on primary outcomes
All analyses will be undertaken by intention to treat at both
the nursing home and patient level. Differences between
the intervention and control group in characteristics of residents and sites at baseline will be tested with appropriate
parametric or non-parametric tests. We will correct for baseline differences between groups in our analyses. We will test
if the longitudinal course of quality of life and positive caregiving experiences differs between the intervention and
usual care group using mixed linear models that include
random effects for nursing home and patients nested within
nursing homes. The models will include fixed effects for
time and intervention group and their two-way interaction.
Confounders will be added as main effects. In particular,
we will adjust for baseline mortality risk using Mitchell’s
12-month mortality risk score86 and its two-way interaction
with time so that any missing data due to death during
follow-up can be considered missing at random. Moderation will be assessed by means of a third-order interaction
between time, intervention group and the moderator with
models containing all lower-order terms. Mediation will be
assessed using Structural Equation Modelling.
Analyses of effects up to in the last phase of life
Because the Namaste Care Family programme includes
end-of-life care, we expect that effects persist until death
(and afterwards for family caregivers, affecting family grief).
For this, we will include specific outcomes, such as comfort
in the dying phase. We will follow an estimated proportion
of 70% of residents until death, based on survival curves
of patients with severe dementia enrolled in the DEOLD
study who have resided in the nursing home for some more
than a year on average.55 We will obtain primary and other
outcomes after death (referring to the period shortly before
death). End-of-life outcomes will be compared between
persons who die within 12 months in the intervention and
usual care group using a mixed model with random effect
for nursing home and a fixed effect for intervention group.
Cost-effectiveness
We will perform an economic evaluation from a societal
perspective. Both cost-effectiveness and cost-utility analyses will be performed with a time horizon of 12 months.
Discounting of costs and effects is not necessary since
follow-up is limited to 12 months.87 Incremental costs per
1-unit decrement on the QUALID scale, per QALY and per
1-unit increment on the PES scale will be estimated. Sensitivity analyses will assess the robustness of the results using
different assumptions regarding costs and effects including
different ways to account for family caregiving time. We
will assess the level of implementation of the Namaste Care
Family programme in relation to outcomes as well as costs.
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Multiple imputations techniques will be used to handle
missing cost and effect data. Incremental cost-effectiveness
ratios (ICERs) will be calculated by dividing the difference in mean total costs between the treatment groups by
the difference in mean effects. Bootstrapping with 5000
replications will be used to estimate 95% CIs around cost
differences and the uncertainty surrounding the ICERs.
Cost-effectiveness planes will graphically present uncertainty surrounding the ICERs. We will estimate cost-effectiveness acceptability curves to show the probability that the
intervention is cost-effective in comparison with usual care
for a range of different ceiling ratios.94 If appropriate, analyses will be adjusted for confounders or moderators that
modify the effect.
Process evaluation and analyses
A mixed-method approach will be used for the process
evaluation. The process evaluation includes qualitative
semistructured interviews after 12 months with nursing
staff, managers, family caregivers and volunteers focusing
on feasibility, accessibility and sustainability. We will analyse
interviews by open and selective coding of content, with
two researchers, independently. Triangulation of interviews
that present different perspectives is used. We will also map
barriers and facilitators of implementation.

Ethics and dissemination
Most participants will have advanced dementia, although
some can have moderate dementia with challenging
behaviour and may therefore respond well to the Namaste
Family Care programme (accordingly, behavioural symptoms of dementia are hypothesised as a moderator in
table 1). Written consent will therefore be obtained from
the primary family caregiver. If judged by the researcher
and/or nursing home as being able to understand information about the study and make an informed decision about
participation, the person with dementia will be asked to
provide written consent as well.
Dissemination
We will publish our findings in peer-reviewed scientific journals and present results at relevant conferences within the
field. A symposium for healthcare professionals working in
long-term care, policy-makers and health insurers will be
organised. The aim will be to inform and motivate attendees
to improve the lives of people with advanced dementia
and their families in the Netherlands. We will develop an
informative short film about the Namaste Care Family
programme which includes interviews with nursing staff,
family caregivers and volunteers about their experiences
with the programme. Based on the results of the process
evaluation, an improved version of the Namaste manuals
will be developed. We will also offer the homes randomised
to the usual care group the opportunity to implement the
Namaste Care Family programme at the end of the study.
This may serve as a pilot test for rolling out the Namaste
Care Family programme more widely in the Netherlands if
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appropriate. The manuals will be made available to interested healthcare professionals, organisations and individual
families and volunteers. The train-the-trainers concept will
retain experienced families and volunteers for further
implementation.
In the future, more people with dementia will be expected
to stay and die at home. Therefore, connecting to people
with dementia and managing behavioural symptoms of
dementia at home are also very important goals for family
caregivers and people with dementia. The application of
the Namaste Care Family programme in a home setting
might be a useful intervention to provide in this setting.
Based on our experiences with Namaste Care Family in
nursing homes, we will develop a Namaste Care Family
manual and training for use at home and will conduct a
pilot study examining the feasibility of the programme
for people with dementia living at home and their family
caregiver(s). People with advanced dementia may be able
to stay at home longer with less challenging behaviour,
lower caregiver burden and more positive family caregiving
experiences.
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Correction

Correction: Effects of the Namaste Care Family programme
on quality of life of nursing home residents with advanced
dementia and on family caregiving experiences: study
protocol of a cluster-randomised controlled trial
Smaling HJA, Joling KJ, van de Ven PM, et al. Effects of the Namaste Care Family
programme on quality of life of nursing home residents with advanced dementia and
on family caregiving experiences: study protocol of a cluster-randomised controlled
trial. BMJ Open 2018;8:e025411. doi: 10.1136/bmjopen-2018-025411.
This article was previously published with the incorrect sentence about the QUALID
below.
We used the mean (M) and SD as calculated in previous work validating the Dutch
version of the QUALID in nursing home residents with advanced dementia (M=7.5,
SD=4.9).41For the PES, it was analysed and provided for the subgroup of family caregivers with dementia (M=2.9, SD=1.9).92
Now, this sentence has been removed and the beginning of the next sentence has been
revised as given below:
The mean PES was analysed and provided for the subgroup of family caregivers with
dementia (M=2.9, SD=1.9).92
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